Why the study?
Are B6D2F1 mice a suitable model for investigating oxidative stress-mediated impaired endothelium-dependent dilation with aging?
Are B6D2F1 mice a suitable model for investigating oxidative stress-mediated impaired endothelium-dependent dilation with aging?
B6D2F1 mice demonstrate age-related, oxidative stress-mediated impairment in endothelium-dependent dilation and increased arterial stiffness, making them a suitable model for vascular aging.
Answers are grounded in this paper and cite their sources.
B6D2F1 mice model age-related oxidative endothelial impairment; leaves open translation to human vascular aging therapies.
To determine if B6D2F1 mice represent a suitable model of oxidative stress-mediated impaired endothelium-dependent dilation (EDD) with aging, mice were studied at 6.9 +/- 0.3 and 31.9 +/- 0.6 months. EDD to acetylcholine (ACh) was 26% (p < .001) and 12% (p < .001) lower, respectively, in isolated carotid (n = 10-11) and femoral (n = 10) arteries from older mice, and reductions in arterial pressure to systemic ACh infusion were smaller in older mice (n = 6-10; p < .01). Nitrotyrosine was marked in aorta of older mice (p < .05, n = 4). Superoxide production in carotid arteries was greater (p < .05), and TEMPOL restored dilation in carotid arteries and systemically in older mice. N(G)-nitro-l-arginine methyl ester (l-NAME) reduced carotid artery dilation in young more than older mice, whereas TEMPOL restored the effects of l-NAME in older mice. Carotid artery stiffness was increased in older compared with young mice (p = .04). Our results provide the first comprehensive evidence that B6D2F1 mice are a useful model for investigating mechanisms of reduced nitric oxide-dependent, oxidative stress-associated EDD and increased arterial stiffness with aging.
No takes yet. Share an insight, caveat, or question.
Lesniewski et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: